|
|
||||||||
Department of Physiology and Biophysics, Indiana University Medical School, Indianapolis, Indiana 46202
| |
ABSTRACT |
|---|
|
|
|---|
Our hypothesis was that a large fraction of resting nitric oxide (NO) formation is driven by flow-mediated mechanisms in the intestinal microvasculature of the rat. NO-sensitive microelectrodes measured the in vivo perivascular NO concentration ([NO]). Flow was increased by forcing the arterioles to perfuse additional nearby arterioles; flow was decreased by lowering the mucosal metabolic rate by reducing sodium absorption. Resting periarteriolar [NO] of large arterioles (first order; 1A) and intermediate-sized arterioles (second order; 2A) was 337 ± 20 and 318 ± 21 nM. The resting [NO] was higher than the dissociation constant for the NO-guanylate cyclase reaction of vascular smooth muscle; therefore, resting [NO] should be a potent dilatory signal at rest. Over flow velocity and shear rate ranges of ~40-180% of control, periarteriolar [NO] changed 5-8% for each 10% change in flow velocity and shear rate. The relationship of [NO] to flow velocity and shear rate demonstrated that 60-80% of resting [NO] depended on flow-mediated mechanisms. Therefore, moment-to-moment regulation of [NO] at rest is an ongoing process that is highly dependent on flow-dependent mechanisms.
microelectrode; intestine; arteriole
| |
INTRODUCTION |
|---|
|
|
|---|
MANY STUDIES (2, 3, 9, 14, 19, 22) have shown that suppression of nitric oxide (NO) formation with L-arginine analogs during in vivo conditions causes substantial vasoconstriction at rest. However, what fraction of the vasoconstriction results from the loss of NO formed in response to flow-mediated mechanisms versus chemical- or environment-mediated mechanisms is unknown. Studies of isolated arterioles (13, 15, 16) demonstrated the potential importance of flow-mediated vasodilation. In those studies, arteriolar responses during flow were compared with the resting diameter at a "no-flow" but pressurized status. From this initial degree of vascular tone, approximately one-half of the basal smooth muscle contractile state, as judged by vasodilation, can be suppressed by increased shear forces within the physiological range. What remains to be determined is the relative role of resting flow-dependent NO formation in the regulation of in vivo microvascular resistance and the physiological significance of the flow-dependent mechanism during reduced and increased blood flows.
In this study, we tested the hypothesis that regulation of large and intermediate-diameter arterioles is highly dependent on flow-mediated mechanisms to stimulate NO production. For this purpose, the microvasculature of the small intestine was chosen. Previous studies by this laboratory (5, 9) demonstrated that the intestinal microvasculature is highly dependent on NO formation. Pharmacological suppression of resting NO formation results in a large increase in vascular resistance by small arteries and large- and intermediate-diameter arterioles (5, 9). Furthermore, when only the metabolic rate of the intestinal mucosa is reduced and villus vascular resistance increases, the larger arterioles outside the influence of the intestinal mucosa also constrict (9). This constriction may reflect decreased NO generation as intestinal blood flow and shear forces are decreased by events initiated in the villus terminal vasculature. To study these mechanisms, measurement of the perivascular and tissue NO concentration ([NO]) was necessary. [NO] was measured using NO-sensitive recessed-tip microelectrodes developed by Buerk and colleagues (10) and previously used in our laboratory to study NO regulation in rats (5, 18). Our current study demonstrates that the production of NO by large- and intermediate-diameter intestinal arterioles is the dominant stimulus for NO formation at rest. Furthermore, flow-dependent mechanisms dominate NO formation over a wide range of physiologically relevant increases and decreases in flow so long as tissue oxygenation is not compromised.
| |
METHODS |
|---|
|
|
|---|
Animal and tissue preparation. Male Sprague-Dawley rats (Harlan, Indianapolis, IN) in the weight range of 400-500 g were used in these experiments. An initial anesthetic dosage of 200 mg/kg of sodium thiopental (7) was given subcutaneously at four sites over the lower back and both thighs of the rat. One-fourth of the original dose was given intraperitoneally if supplemental anesthesia was needed. The trachea was cannulated with polyethylene tubing to ensure a patent airway, and the left femoral artery was cannulated to measure arterial blood pressure. The small intestine was prepared for observation with an established technique (4). The intestine was bathed at a rate of 4-5 ml/min with heated (37.5 ± 0.5°C) bicarbonate-buffered physiological saline (4) equilibrated with 5% oxygen, 5% carbon dioxide, balance nitrogen. The tissue support device was also heated to 37.5 ± 0.5°C. The rat's body was maintained at 37.5-38°C and heated by a water jacket support held at 34-35°C.
All animals were ventilated using a Harvard Apparatus small animal ventilator (model 683, Harvard Apparatus, South Natick, MA) using a ventilation frequency of 70 breaths/min, the typical ventilation frequency of quiet, conscious adult rats. The tidal volume was based on the Harvard Apparatus nomogram; in addition, 1 ml was added per breath to compensate for the dead space of the cannula system. The end-tidal partial pressure of carbon dioxide was measured (model SC-210 CO2 monitor, Pyron, Menomonee Falls, WI) throughout the experiment. The tidal volume was adjusted until the steady-state end-tidal carbon dioxide tension was 38-40 mmHg. The rats maintained a stable mean arterial pressure of 105-120 mmHg so long as they were ventilated and given ~0.5 ml saline/100 g body wt every hour to compensate for urinary and ventilatory fluid losses.NO measurement.
[NO] was measured using the polarographic technique with glass
microelectrodes that had a tip diameter of 6-10 µm and a open recessed tip of 20-30 µm, which was preceded with gold plating for a distance of 50-100 µm. The electrode recess was filled by immersion with Nafion (Aldrich Chemical, Milwaukee, WI), which dried to
a thin coating <1 µm in thickness. The techniques for producing and
calibrating NO-sensitive microelectrodes are based on the procedures
developed by Buerk and colleagues (10) and our experience
with the microelectrodes (5, 18). The NO-sensitive microelectrodes were polarized at +0.8 V relative to a World Precision Instruments carbon fiber reference electrode (Sarasota, FL). Currents in the picoampere range were measured with a Keithley model 610C electrometer (Cleveland, OH). The typical NO microelectrode had currents in the range of 8-12 pA in nitrogen-equilibrated saline and for a 1,000 nM increase in NO would generate an additional current
of 1-2 pA. This translates to a 300- to 600-mV increase in voltage
output on the Keithley electrometer per 1,000 nM of NO. A Diamond
General gas tonometer system (Ann Arbor, MI) was used to establish
[NO] of 0, ~600, and ~1,200 nM, based on the composition of the
NO-N2 precision calibration gases (Matheson, Joliet, IL) in
saline at 37.5°C. Each electrode was found to have a linear
current-[NO] relationship. The working resolution of the
microelectrodes, taking into account noise and current drift, was
typically
10 nM at an average resting vessel wall [NO] of 300-325 nM. After each experiment, NO sensitivity was retested in
the calibration system and generally found to have changed less than
±10% unless the micropipette tip was fouled with tissue residue or
damaged. In general, the NO-sensitive microelectrodes were usable over
three to four experiments.
1 mM
tyrosine in saline equilibrated with nitrogen. Because 1 mM is about
five times higher than the in vivo plasma concentration of tyrosine in
rats (23), naturally occurring tyrosine should have
negligible consequences on the NO measurements we report.
During measurement of periarteriolar [NO], the microelectrode tip was
pushed through the visceral muscle layers and lightly pressed against
the vessel wall. Penetration of the wall was avoided because vessel
wall injury causes a transient to sustained increase in [NO]. As the
vessel changed diameter or the intestine moved slightly, a precision
hydraulic micromanipulator was used to carefully maintain
microelectrode tip-vessel wall contact.
The NO measurements in this study often required 20-30 min for a
control, response, and recovery period. Because all polarographic microelectrodes have some amount of current drift with time, the effect
of drift on [NO] measurements must be taken into consideration. For
microelectrodes that have been polarized for 12-24 h, current drift was essentially linear with time for ~1 h. Therefore, the currents in bathing fluid before and after a tissue measurement began
and the intervening time were recorded. These data were used to
calculate the rate of drift of the baseline current and the
interpolated baseline current at any given time during the measurement
period. In this way, the interpolated baseline current at the time of a
tissue current measurement could be subtracted to yield the current
generated by NO. The average rate of current drift for all 74 of the
long-term successful measurements was equivalent to 18 ± 6 nM/10
min. However, with correction for current drift, this inadvertent error
signal did not interfere with the measurements of vessel wall [NO].
Flow velocity measurements.
Red blood cell velocity was measured with the dual-slit
cross-correlation technique using an Instrumentation for Physiology and
Medicine model 102 system (San Diego, CA). The system was calibrated
for linear velocities by measuring the velocity of dried red blood
cells on a clear disk rotated by a 1-rpm synchronous motor. The disk
radius at specific points was known and used to calculate
circumferential velocity. When the centerline flow velocity was
measured in vivo, this velocity was divided by 1.6 to estimate the
average red blood cell velocity for microvessels with diameters >10
µm (1). The site of vessel velocity and vessel diameter measurements was ~50 µm upstream from the site for [NO]
measurement. Vessel diameter was measured from the digitized
freeze-frame video image (CCD Camera 200R, Videoscope International,
Washington, DC) using the virtual caliper function of Image 1 image
analysis software (Universal Imaging, West Chester, PA). The image
analysis system was calibrated in the X and Y
directions using the image of a stage micrometer marked in 10- and
100-µm units. Once both the mean velocity and inner diameter were
known, shear rate was calculated using 4 × mean velocity/inner
radius to yield s
1 which is equivalent to the formal
equation of (4 × flow)/(3.14 × radius3).
Protocols.
A diagrammatic scheme of the intestinal microvessels studied is shown
in Fig. 1. The larger arterioles
[first-order arterioles (1A)] ran radially about halfway around the
bowel wall. These 1A originated from the marginal arteries along the
mesenteric aspect of the bowel wall. The intermediate-sized arterioles
[second-order arterioles (2A)] chosen were the largest
interconnecting arterioles between adjacent 1A. These 2A were typically
the first two branches of the 1A. The larger 2A were chosen because
they perfused a great number of terminal arterioles, shown as small
spur branches in Fig. 1. The terminal arterioles supply the deep
submucosa, villi, and overlying muscle layers. The directions of flow
for each vessel type during each protocol and the measurement locations
for flow velocity, inner arteriolar diameter, and [NO] are shown in
Fig. 1.
|
Decreased metabolic rate. As explained in the introduction, isosmotic replacement of sodium chloride with mannitol over the villi lowers the resting intestinal metabolic rate and blood flow over a period of 15-20 min (9). The perfusion pattern did not change during periods of reduced metabolic rate and was identical to the normal pattern illustrated in the top panel of Fig. 1. Furthermore, percent saturation of hemoglobin measurements during periods of reduced blood flow indicated that arteriolar oxygen tensions change very little in the 1A and 2A (9). The outer surface of the bowel wall, where the measurements of 1A and 2A were made, was constantly bathed (4-5 ml/min) with standard physiological solution. However, some of the mannitol solution from the mucosal surface perfusion (1 ml/min) did mix with the physiological saline. This is not a problem. If only the exterior of the bowel wall was perfused with the mannitol-bicarbonate solution, the resting intestinal blood flow was not affected (9).
The protocol consisted of measurement of microvascular parameters during perfusion of the mucosal layer with standard physiological solution, switch to mannitol-bicarbonate solution, and remeasurement of all parameters after 15-20 min. The NO microelectrode was withdrawn from the periarteriolar site during fluid changes to avoid the possibility of the microelectrode tip damaging the vessel during tissue movement. Once arteriolar diameter responses to a given solution were stable, the microelectrode was reinserted at the same location and measurements continued. The mannitol-bicarbonate protocol has been shown to be completely benign to the intestine and its vasculature and can be repeated as often as needed with no obvious consequences (9).Collateral perfusion. The goal of this protocol was to increase resting blood flow through the arterioles being studied as they become collateral vessels to perfuse vessels in adjacent areas of the bowel wall. This was accomplished by nontraumatically occluding the adjacent 1A (see Fig. 1, middle). In most cases, the NO microelectrode was left in place during the occlusion of these very distal 1A. The 1A and 2A providing collateral perfusion were in an area of tissue that was always normally perfused. Furthermore, venous drainage from the flow-deprived tissue was through its normal venous outflow channel beside the occluded 1A. Therefore, the primary stimuli to the 1A and 2A providing collateral flow should be some aspect of flow-mediated vasodilation rather than vasoactive materials in venous blood from the flow-deficient areas of tissue. The blood flow increased in the vessels studied, and the parenchymal tissues they naturally perfused received normal blood flow. Therefore, the oxygen tension within and around these vessels was not compromised by this protocol.
On occlusion of the adjacent 1A, flow increased in the collateral 1A and 2A, and the flow direction reversed in the dependent 2A, as shown in the middle panel of Fig. 1. This flow direction transition was very rapid, requiring <5 s. However, the development of flow-mediated vasodilation and the concomitant increase in [NO] required up to 90 s to reach steady state. On release of the occluded 1A, recovery of all the vessels studied occurred within a 2- to 3-min period.Upstream occlusion. To reduce the flow in the 1A being studied, the upstream small artery was occluded for several minutes with a blunt glass micropipette. The NO microelectrode was kept in place during the brief occlusion. This pattern of perfusion is shown in the bottom panel of Fig. 1. For the 2A, flow direction reversed in the vessels near the mesenteric wall and provided some flow to the 1A. The distal 2A along the occluded 1A had variable flow directions from moment to moment, but in general, flow was in the normal direction.
Statistical analysis. All data are expressed as means ± SE, and statistical analysis was carried out using Sigma Stat (Jandel Scientific, San Rafael, CA). To evaluate differences in each variable, comparisons were made with repeated-measures one-way analysis of variance relative to the initial control condition.
| |
RESULTS |
|---|
|
|
|---|
Microelectrode evaluation.
Although the NO-sensitive microelectrodes demonstrated a linear
relationship between [NO] and current generated in a gas tonometer, whether the tissue physical and chemical environment offsets the relationship or induces artifacts has not been established. The oxygen
in living tissue presented a formidable problem to calibration of a
microelectrode using externally supplied NO during both in vitro and in
vivo conditions. To circumvent this problem, the blood flow was
stopped, the tissue was frozen in the tissue support device to stop all
metabolism, and then the tissue was rewarmed to body temperature. This
approach was used in the classic studies of oxygen-sensitive
microelectrodes by Whalen et al. (25) to provide a
"tissue" calibration of polarographic microelectrodes. This same
procedure allowed us to work in an oxygen-free environment. Furthermore, in an oxygen-free environment, any chemicals in the freeze-damaged cells could interact with the microelectrode to cause an
electrical current error signal. However, as shown in Fig.
2, the currents measured by the same
microelectrode in the nitrogen-equilibrated bath and in the tissue at a
depth of 20-25 µm were identical for practical purposes. An
arteriole in the submucosal tissue was used as a tissue target to
provide consistent-depth penetrations. Starting from a
nitrogen-equilibrated state, ~400 parts per million NO gas in
nitrogen was added in stages to the bathing medium reservoir to
progressively increase [NO]. The calculated maximum concentration
achievable would be ~600 nM at 37.5°C. Measurements of bath and
tissue were taken once the bath [NO] stabilized for at least 3-5
min after addition of NO to the reservoir to allow equilibration of the
tissue to the new [NO]. Figure 2 lists the range of lowest (0 nM NO
during nitrogen equilibration) to highest [NO] achieved for each
microelectrode based on the independent calibration of each
microelectrode in a precision gas tonometer. Over the range of [NO]
tested, the microelectrodes recorded almost the same current in the
tissue as in the bath for a given [NO], as demonstrated by
tissue-bath current slopes >0.9 and correlation coefficients >0.9.
This is good evidence that the physical environment of the tissue and
any biochemicals that survived freezing had little effect on the
microelectrode's ability to faithfully monitor the [NO] in the
physical environment of the tissue. However, although the
microelectrodes were stable during careful tissue penetration, obvious
bending of the microelectrode tip caused large current offsets.
|
|
|
Vessel characteristics.
The resting inner diameter, flow velocity, shear rate, and
periarteriolar [NO] are presented in Table
1. In each animal studied, the 2A was a
branch of the 1A studied. As mentioned in METHODS, the 2A
selected were the first or second 2A branch of a given 1A. These
arterioles were typically larger in diameter than the more distal 2A
branches and were the primary collateral connectors between adjacent 1A
(Fig. 1). Despite major differences in vessel diameters and
flow-related variables between 1A and 2A, the average resting [NO]
for all 1A was 337 ± 20 (74 vessels, 29 rats) and 318 ± 21 (35 vessels, 21 rats) nM for the 2A.
|
Reduced metabolic rate.
Isosmotic replacement of luminal sodium chloride with
mannitol-bicarbonate solution is known to both reduce the intestinal metabolic rate and increase the resistance of the terminal and larger
arterioles (9). As shown in Fig.
5, blood flow was reduced to 60-65%
of control, which was consistent with prior studies in which reduced
intestinal metabolism resulted in significantly increased resistance of
small arteries and both 1A and 2A (9). The reductions in
shear rate and flow velocity in the 1A and 2A were associated with
~30% and ~20% decrease in periarteriolar [NO],
respectively. The 20-30% reduction in periarteriolar
[NO], as well as arteriolar constriction, required ~15 min to reach steady state. The time delay was caused by the intentionally slow changes in mucosal luminal fluid performed to avoid dislodging micropipettes and stretching the tissue. Once steady-state reductions in hemodynamic parameters and [NO] were achieved, they persisted for
at least an hour, which was the longest time used for testing. Restoration of sodium chloride in the luminal media over the villi resulted in complete recovery of all hemodynamic and [NO] parameters within ~15 min.
|
Collateral perfusion studies.
The data shown in Figs. 6 and
7 are for arterioles that provided
collateral blood flow to an adjacent tissue area whose inflow 1A had
been occluded. This pattern of perfusion is shown in the middle panel
of Fig. 1. Blood flow increased in the 1A and 2A because they must
perfuse their own tissue regions plus a large amount of an adjacent
1A-2A perfusion field (Fig. 1).
|
|
Upstream occlusion studies.
The purpose of these studies was to both reduce flow velocity in the 1A
and force a decrease in oxygen availability to the vessel and nearby
tissue (Fig. 8). We used these studies to
demonstrate that [NO] will increase despite a reduction in flow
velocity and shear rate if oxygen availability is limited. After
initial control measurements were made, the origin of the 1A was
occluded just outside the intestinal wall. The occlusion was
~6,000-7,000 µm from the 1A observation area. This perfusion
pattern is shown in the bottom panel of Fig. 1. The retrograde
perfusion of 2A provided ~50% of the normal flow in the 1A whose
origin was occluded. Although we did not measure the oxygen tension in
the 1A, the color of blood darkened because of oxygen desaturation as
it flowed retrograde through the 2A to the 1A. Despite the large
decrease in flow velocity and shear rate, [NO] in the 1A increased to
127 ± 5% of control. In addition, the 1A was able to maintain
its resting diameter despite a large reduction in perfusion. In our prior experience with occlusion of 1A, microvascular pressure was
typically reduced by about one-half (17).
|
Velocity and shear rate effects on [NO].
The relationship of [NO] to percentage of control red blood cell
velocity and shear rate in all of the 1A and 2A is shown in Fig.
9. These data are based on the results
obtained during the collateral and metabolic protocols (Figs. 5 and 7)
for each of the vessels studied. Normalization of the data was used
because, in reviewing responses by individual vessels, the [NO]
changed in approximate proportion to the flow velocity and shear rate. However, as one might expect, there was a wide range of velocities and
shear rates even within the same vessel as daughter branches were given
off and the vessel gradually tapered to smaller diameters over
distance. The slopes of the relationships for velocity and shear rate
of 1A [NO] were 0.85 and 0.75, respectively, and for 2A [NO] were
0.59 and 0.52, respectively, for velocity and shear rate. These data
predict that NO formation in larger arterioles is more dependent on
flow-related mechanisms than that in intermediate diameter arterioles.
|
| |
DISCUSSION |
|---|
|
|
|---|
Resting periarteriolar [NO].
The resting periarteriolar [NO] was of interest in the context of
what fraction of maximum activity of vascular smooth guanylate cyclase
might be generated. Stone and Marletta (24) reported the
in vitro [NO] for half-maximal activation of guanylate cyclase in
vascular smooth muscle to be
250 nM [dissociation constant (Kd)] at 10°C. The physiological
Kd at 37-38°C should be a somewhat higher
concentration, but just how much higher remains to be determined. However, within the limitations of current knowledge, the [NO] we
measured at the outer surface of the arteriolar wall should generate
approximately half-maximum cGMP. The resting [NO] can be increased by
~100%. Supraphysiological 1 mM L-arginine and 360 mosM
sodium chloride (5) are both capable of nearly doubling the [NO], as is also the case during the highest possible
physiological increases in flow velocity and shear rate during
collateral perfusion events (Fig. 9). Therefore, we believe that the
resting [NO] was about one-half the physiological maximum
concentration that in vivo intestinal arterioles can generate for
sustained periods. We have recorded >200% of control [NO] but only
after vessel wall injury by penetration of the endothelial layer or
severe hypoxia, and these increases are invariably transient.
Effect of flow-mediated stimuli on [NO]. To confirm that endothelial cells were the source of NO during flow perturbations, [NO] at rest and at elevated blood flow was measured before and after localized oxygen embolization of large arterioles. Nase and Boegehold (20) showed that localized gas embolization virtually eliminated endothelium-dependent vasodilation to locally applied acetylcholine. On the basis of their observations, we tested whether flow-dependent increases in [NO] and associated vasodilation were eliminated by oxygen bubble emobolization. The localized endothelial damage immediately reduced the resting [NO] by ~40%, as shown in Fig. 6. In a prior study of intestinal arterioles (5), we found that topical NG-nitro-L-arginine applied topically to a single large arteriole in the intestinal wall caused a comparable decrease in resting [NO]. When blood flow was increased after embolization, the vessels did not increase either [NO] or inner diameter. However, the other arterioles in the area continued to respond with appropriate dilation to increased blood flow. These various observations indicated that vasodilation to increased flow velocity was highly dependent on an intact endothelium and was associated with a relatively large increase in [NO].
An essential goal of this study was to determine what fraction of the resting [NO] is generated in response to flow-mediated versus other non-flow-dependent processes. This laboratory (6) has shown that ~70% of the increased resistance after NG-nitro-L-arginine methyl ester or topical 300 mg/dl hyperglycemia with L-glucose was caused by constriction of the smallest arteries and larger arterioles. These latter vessels are the 1A and 2A evaluated in the current study. These earlier data predicted that NO was a major determinant of vascular resistance at rest. However, we could only speculate that flow-dependent mechanisms accounted for most of the NO generation at rest. To address this issue, we measured [NO] as flow velocity and shear rate were raised or lowered without risking oxygen availability to the tissue. The combined data in Fig. 9 summarize responses to both increased and decreased blood flow during normoxic conditions with the various protocols depicted in Figs. 5 and 7. We found that [NO] in the 1A changed ~8.5% and 7.5% for each 10% change in flow velocity and shear rate, respectively. The data for the 2A were a 5.2% and 5.9% change in [NO] for each 10% change in flow velocity and shear rate, respectively. These data predicted that the larger arterioles were more dependent on flow-related physical forces to generate NO than the smaller vessels. In this same context, if we extrapolated the data to a zero flow or shear rate status, the [NO] intercept would predict that only 20% of the resting [NO] would exist in large arterioles and ~40% in the intermediate diameter arterioles (Fig. 9). On the basis of this analysis of the slope of [NO] to flow-dependent variables and its intercept, the endothelial response to resting blood flow velocity and shear rate should generate ~60-80% of the resting [NO]. As previously mentioned, the resting [NO] for both 1A and 2A was sufficiently high to approach half-maximal activation of cGMP as currently understood for vascular smooth muscle. Therefore, flow-mediated stimulation of NO formation is an important, if not dominant, contributor to resting regulation of NO formation in the major resistance arterioles studied.Effect of hypoxia on NO formation. The results and conclusions discussed thus far are for conditions in which reduced tissue oxygenation was not an issue during variations in blood flow. Our interest in tissue oxygenation and NO formation was stimulated by Busse and colleagues' (11) and Pohl and Busse's (21) finding that hypoxia is a stimulus for NO-mediated vasodilation. The data in Fig. 8 represent conditions when flow into a 1A was reduced by complete upstream occlusion of its origin at the bowel wall-mesenteric border. Thereafter, the perfusion of the 1A was ~50% of normal through retrograde perfusion of the larger 2A near the mesenteric border of the bowel wall. Although we did not measure the oxygen tension in the vessel wall of 1A, the color of the blood darkened, indicating oxygen desaturation. Despite the ~50% reduction of the flow velocity and shear rate, [NO] increased an average of 27% (Fig. 8) and the arterioles dilated ~10%. In contrast, for a similar magnitude reduction in flow velocity and shear rate when the metabolic rate was decreased, both a 20-30% reduction in [NO] and 10% arteriolar constriction occurred (Fig. 5). The net difference in [NO] between the two "low-flow" states was 50-60% of control, which corresponded to a [NO] difference of 175-200 nM. This was a large difference in [NO]. For example, the [NO] increased ~40-50% or ~120-175 nM during the transition from rest to maximal collateral blood flow (Fig. 9). In effect, compromising tissue oxygenation completely changes the regulation of NO formation from a mechanism dominated by flow-dependent forces to a potentially very complex set of mechanisms related to the diverse effects of hypoxia on vascular and parenchymal tissue. As a consequence, understanding the regulation of NO through flow-dependent and non-flow-dependent mechanisms during in vivo studies depends critically on whether tissue oxygenation is compromised by a given perturbation.
| |
ACKNOWLEDGEMENTS |
|---|
The authors appreciate the technical assistance of Mary Ann Neil.
| |
FOOTNOTES |
|---|
This study was supported by National Heart, Lung, and Blood Institute Grants HL-20605 and HL-25827. G. P. Nase was supported by a postdoctoral fellowship from the Indiana Affiliate of the American Heart Association.
Address for reprint requests and other correspondence: H. G. Bohlen, Dept. of Physiology and Biophysics, Indiana Univ. Medical School, 635 Barnhill Dr., Indianapolis, IN 46202 (E-mail: gbohlen{at}iupui.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 18 October 1999; accepted in final form 17 May 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Baker, M,
and
Wayland H.
On-line volume flow rate and velocity profile measurement for blood in microvessels.
Microvasc Res
7:
131-143,
1974[Web of Science][Medline].
2.
Boegehold, M.
Reduced influence of nitric oxide on arteriolar tone in hypertensive Dahl rats.
Hypertension
19:
290-295,
1992
3.
Boegehold, MA.
Shear-dependent release of venular nitric oxide: effect on arteriolar tone in rat striated muscle.
Am J Physiol Heart Circ Physiol
271:
H387-H395,
1996
4.
Bohlen, HG.
Determinants of resting and passive intestinal vascular pressures in rat and rabbit.
Am J Physiol Gastrointest Liver Physiol
253:
G587-G595,
1987
5.
Bohlen, HG.
Mechanism of increased vessel wall nitric oxide concentrations during intestinal absorption.
Am J Physiol Heart Circ Physiol
275:
H542-H550,
1998
6.
Bohlen, HG,
and
Lash JM.
Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilation of normal rat arterioles.
Am J Physiol Heart Circ Physiol
265:
H219-H225,
1993
7.
Bohlen, HG,
and
Lash JM.
Endothelial-dependent vasodilation is preserved in non-insulin-dependent Zucker fatty diabetic rats.
Am J Physiol Heart Circ Physiol
268:
H2366-H2374,
1995
8.
Bohlen, HG,
and
Lash JM.
Resting oxygenation of rat and rabbit intestine: arteriolar and capillary contributions.
Am J Physiol Heart Circ Physiol
269:
H1342-H1348,
1995
9.
Bohlen, HG,
and
Lash JM.
Intestinal absorption of sodium and nitric oxide-dependent vasodilation interact to dominate resting vascular resistance.
Circ Res
78:
231-237,
1996
10.
Buerk, DG,
Riva CE,
and
Cranstoun SD.
Nitric oxide has a vasodilatory role in cat optic nerve head during flicker stimuli.
Microvasc Res
52:
13-26,
1996[Web of Science][Medline].
11.
Busse, R,
Pohl U,
Kellner C,
and
Klemm U.
Endothelial cells are involved in the vasodilatory response to hypoxia.
Pflügers Arch
397:
78-80,
1983[Web of Science][Medline].
12.
Guo, J-P,
Murohara T,
Buerke M,
Scalia R,
and
Lefer AM.
Direct measurement of nitric oxide release from vascular endothelial cells.
J Appl Physiol
81:
774-779,
1996
13.
Koller, A,
and
Kaley G.
Endothelial regulation of wall shear stress and blood flow in skeletal muscle microcirculation.
Am J Physiol Heart Circ Physiol
260:
H862-H868,
1991
14.
Koller, A,
Messina EJ,
Wolin MS,
and
Kaley G.
Endothelial impairment inhibits prostaglandin and EDRF-mediated arteriolar dilation in vivo.
Am J Physiol Heart Circ Physiol
257:
H1966-H1970,
1989
15.
Koller, A,
Sun D,
Huang A,
and
Kaley G.
Corelease of nitric oxide and prostaglandins mediates flow-dependent dilation of rat gracilis muscle arterioles.
Am J Physiol Heart Circ Physiol
267:
H326-H332,
1994
16.
Kuo, L,
Davis MJ,
and
Chilian WM.
Endothelium-dependent, flow-induced dilation of isolated coronary arterioles.
Am J Physiol Heart Circ Physiol
259:
H1063-H1070,
1990
17.
Lash, JM,
Bohlen HG,
and
Waite L.
Mechanical characteristics and active tension generation in rat intestinal arterioles.
Am J Physiol Heart Circ Physiol
260:
H1561-H1574,
1991
18.
Lash, JM,
Nase GP,
and
Bohlen HG.
Acute hyperglycemia depresses arteriolar NO formation in skeletal muscle.
Am J Physiol Heart Circ Physiol
277:
H1513-H1520,
1999
19.
Nakamura, T,
and
Prewitt RL.
Effect of NG-monomethyl-L-arginine on arcade arterioles of rat spinotrapezius muscles.
Am J Physiol Heart Circ Physiol
261:
H46-H52,
1991
20.
Nase, GP,
and
Boegehold MA.
Endothelium-derived nitric oxide limits sympathetic neurogenic constriction in intestinal microcirculation.
Am J Physiol Heart Circ Physiol
273:
H426-H433,
1997
21.
Pohl, U,
and
Busse R.
Hypoxia stimulates release of endothelium-derived relaxant factor.
Am J Physiol Heart Circ Physiol
256:
H1595-H1600,
1989
22.
Steenbergen, JM,
and
Bohlen HG.
Sodium hyperosmolarity of intestinal lymph causes arteriolar vasodilation in part mediated by EDRF.
Am J Physiol Heart Circ Physiol
265:
H323-H328,
1993
23.
Stingele, R,
Wilson D,
Traystman RJ,
and
Hanley DF.
Tyrosine confounds oxidative electrochemical detection of nitric oxide.
Am J Physiol Heart Circ Physiol
274:
H1698-H1704,
1998
24.
Stone, JR,
and
Marletta MA.
Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide.
Biochemistry
35:
1093-1099,
1996[Medline].
25.
Whalen, WJ,
Riley J,
and
Nair P.
A microelectrode for measuring intracellular PO2.
J Appl Physiol
23:
798-801,
1967
This article has been cited by other articles:
![]() |
H. G. Bohlen, X. Zhou, J. L. Unthank, S. J. Miller, and R. Bills Transfer of nitric oxide by blood from upstream to downstream resistance vessels causes microvascular dilation Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1337 - H1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhou, H. G. Bohlen, S. J. Miller, and J. L. Unthank NAD(P)H oxidase-derived peroxide mediates elevated basal and impaired flow-induced NO production in SHR mesenteric arteries in vivo Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1008 - H1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Bauser-Heaton and H. G. Bohlen Cerebral microvascular dilation during hypotension and decreased oxygen tension: a role for nNOS Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2193 - H2201. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Kim, F. A. Sanchez, R. G. Duran, T. Kanetaka, and W. N. Duran Endothelial nitric oxide synthase is a molecular vascular target for the Chinese herb Danshen in hypertension Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2131 - H2137. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Tsai, P. Cabrales, B. N. Manjula, S. A. Acharya, R. M. Winslow, and M. Intaglietta Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers Blood, November 15, 2006; 108(10): 3603 - 3610. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kavdia and A. S. Popel Venular endothelium-derived NO can affect paired arteriole: a computational model Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H716 - H723. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. P. Romanko and D. W. Stepp Reduced constrictor reactivity balances impaired vasodilation in the mesenteric circulation of the obese Zucker rat Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2097 - H2102. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Zani and H. G. Bohlen Transport of extracellular L-arginine via cationic amino acid transporter is required during in vivo endothelial nitric oxide production Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1381 - H1390. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Tsai, C. Acero, P. R. Nance, P. Cabrales, J. A. Frangos, D. G. Buerk, and M. Intaglietta Elevated plasma viscosity in extreme hemodilution increases perivascular nitric oxide concentration and microvascular perfusion Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1730 - H1739. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Zani and H. G. Bohlen Sodium channels are required during in vivo sodium chloride hyperosmolarity to stimulate increase in intestinal endothelial nitric oxide production Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H89 - H95. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chu and H. G. Bohlen High concentration of glucose inhibits glomerular endothelial eNOS through a PKC mechanism Am J Physiol Renal Physiol, September 1, 2004; 287(3): F384 - F392. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Unthank, K. M. Sheridan, and M. C. Dalsing Collateral Growth in the Peripheral Circulation: A Review Vascular and Endovascular Surgery, July 1, 2004; 38(4): 291 - 313. [Abstract] [PDF] |
||||
![]() |
M. Kavdia and A. S. Popel Contribution of nNOS- and eNOS-derived NO to microvascular smooth muscle NO exposure J Appl Physiol, July 1, 2004; 97(1): 293 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Bohlen Protein kinase {beta}II in Zucker obese rats compromises oxygen and flow-mediated regulation of nitric oxide formation Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H492 - H497. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Nase, J. Tuttle, and H. G. Bohlen Reduced perivascular PO2 increases nitric oxide release from endothelial cells Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H507 - H515. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Thom, D. Fisher, J. Zhang, V. M. Bhopale, S. T. Ohnishi, Y. Kotake, T. Ohnishi, and D. G. Buerk Stimulation of perivascular nitric oxide synthesis by oxygen Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1230 - H1239. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Bohlen and G. P. Nase Obesity lowers hyperglycemic threshold for impaired in vivo endothelial nitric oxide function Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H391 - H397. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Sauls and M. A. Boegehold Adenosine linking reduced O2 to arteriolar NO release in intestine is not formed from extracellular ATP Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1193 - H1200. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |